Lausanne, Switzerland

Antoine Daina

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Antoine Daina

Introduction

Antoine Daina is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate ghrelin receptor activity. With a total of 4 patents to his name, Daina's work is paving the way for advancements in the treatment of various diseases.

Latest Patents

Daina's latest patents include groundbreaking research on "Substituted asymmetric ureas as modulators of ghrelin receptor activity." This patent discloses compounds, compositions, and methods aimed at preventing and treating diseases mediated by the ghrelin receptor. The compounds are characterized by a general Formula I or their pharmaceutically acceptable salts. Another significant patent is focused on "Benzenesulfonyl-asymmetric ureas and medical uses thereof," which provides these compounds for treating conditions modulated by the ghrelin receptor.

Career Highlights

Antoine Daina is currently associated with Helsinn Healthcare SA, where he continues to innovate in the pharmaceutical sector. His work is instrumental in developing new therapeutic strategies that address unmet medical needs.

Collaborations

Daina collaborates with esteemed colleagues such as Claudio Giuliano and Claudio Pietra, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Antoine Daina's contributions to medicinal chemistry and his innovative patents highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…